Durgical
EN
Open the app

HIV-1 vs HIV-2

  • Topic

HIV-2 causes the same disease as HIV-1 but more slowly, and tests and drugs made for HIV-1 can miss or fail it.

Updated

What it is

HIV-1 and HIV-2 are two related retroviruses that infect CD4 T cells and can cause AIDS. HIV-1 causes most infections worldwide; HIV-2 is concentrated in West Africa and in countries with ties to it. HIV-2 keeps a lower viral load, spreads less easily and progresses more slowly, but it needs its own viral load test and does not respond to several HIV-1 drugs.

Step by step

  1. Both viruses infect CD4 T cells and, untreated, can deplete them until opportunistic infections appear.
  2. HIV-2 keeps plasma viral load low or even undetectable in most patients, although it still hides in cells as proviral DNA.
  3. Less virus in blood and genital fluids means fewer infections passed to partners and babies.
  4. Less virus also means a slower CD4 fall, a longer symptom-free phase, and fewer people reaching AIDS.
  5. HIV-2 enzymes and envelope differ: the NNRTI pocket and the enfuvirtide target do not fit, and some protease inhibitors bind less well.
  6. So an HIV-1 viral load or an NNRTI regimen applied to HIV-2 gives false reassurance or treatment failure.

HIV-1 vs HIV-2: what changes

FeatureHIV-1HIV-2
Where it is foundWorldwide; most HIV infectionsWest Africa (highest in Guinea-Bissau, around 8% of adults); countries with ties to the region, such as Portugal and France
TransmissionEfficient sexual and mother-to-child transmissionLess efficient: sexual transmission 5–9 times and mother-to-child transmission 10–20 times lower than HIV-1
Course without treatmentMost progress to AIDSLower viral load, slower CD4 fall, longer asymptomatic phase; only 15–25% progress to AIDS, but those who do get the same opportunistic infections
DiagnosisAntigen/antibody screen, then HIV-1/HIV-2 differentiation immunoassay; HIV-1 RNA test if results disagreeSame screen; the differentiation immunoassay names HIV-2 (or leaves it undifferentiated); confirmation needs HIV-2-specific RNA testing
Viral loadStandard HIV-1 RNA testsHIV-1 tests do not measure it; HIV-2 RNA assays, often specialised or in-house; frequently low or undetectable
Drug susceptibilityAll main classes activeNaturally resistant to NNRTIs and enfuvirtide; reduced to some protease inhibitors (atazanavir, nelfinavir, tipranavir); darunavir, lopinavir and saquinavir active; integrase inhibitors and NRTIs active

Clinical notes

  • Think of HIV-2 in people from West Africa or with partners from there, and in Portugal- or France-linked patients.
  • A person with a positive HIV screen, a low CD4 count and an 'undetectable' HIV-1 viral load without treatment may have HIV-2.
  • Where differentiation tests are not available, HIV-2 can be treated by mistake with NNRTI-based regimens that do not work on it.

In the lab

  • Step 1: antigen/antibody immunoassay that detects HIV-1 and HIV-2 antibodies and HIV-1 p24 antigen.
  • Step 2: if reactive, an immunoassay that differentiates HIV-1 from HIV-2 antibodies.
  • Step 3: if step 2 is negative or indeterminate, an HIV-1 nucleic acid test; HIV-2 or undifferentiated results go to HIV-2-specific testing.
  • Follow-up: CD4 count plus an HIV-2 RNA viral load, not an HIV-1 assay.

Common traps

  • An undetectable HIV-1 viral load in HIV-2 means good control: HIV-1 assays do not measure HIV-2; only an HIV-2 RNA test tells.
  • HIV-2 is harmless: most people progress slowly, but without treatment some develop AIDS with the same opportunistic infections.
  • Any first-line HIV regimen works for HIV-2: NNRTIs (efavirenz, nevirapine) and enfuvirtide never work, and some protease inhibitors are weaker; regimens use NRTIs with an integrase inhibitor or an active protease inhibitor such as darunavir.
  • A reactive screen with a negative HIV-1 differentiation result is a false positive: it may be HIV-2 or very early HIV-1, so RNA testing comes next.

Test yourself

Think of the answer, then tap the question to see it.

A man from Guinea-Bissau has a reactive HIV screen, a CD4 count that has fallen over years and an undetectable HIV-1 viral load without treatment. What is the likely explanation and the next test?

HIV-2 infection: HIV-1 viral load tests do not measure HIV-2. The differentiation immunoassay and an HIV-2-specific RNA test are next.

Why is HIV-2 passed on less often, both sexually and from mother to child?

It keeps a much lower viral load in blood and genital fluids, so each exposure carries less virus.

Which antiretroviral classes do not work against HIV-2, and which are relied on instead?

NNRTIs and the fusion inhibitor enfuvirtide do not work, and some protease inhibitors are weaker; NRTIs with an integrase inhibitor (or an active protease inhibitor such as darunavir) are used.

Is HIV-2 a benign infection that never needs attention?

No. It progresses more slowly and only a minority reach AIDS, but untreated HIV-2 can still cause AIDS with the same opportunistic infections.

Add to my cards (4)

Connections

← All of immunology

Educational content on the immune system; not a treatment or individual vaccination guide and no substitute for a health professional's advice. No doses are given.

Sources: Human Immunodeficiency Virus Type 2: The Neglected Threat (Pathogens (Ceccarelli G et al.), via PubMed Central, 2021); Antiretroviral Treatment of HIV-2 Infection: Available Drugs, Resistance Pathways, and Promising New Compounds (International Journal of Molecular Sciences (Moranguinho I et al.), via PubMed Central, 2023); Laboratory Testing for the Diagnosis of HIV Infection: Updated Recommendations (Centers for Disease Control and Prevention (CDC) and Association of Public Health Laboratories, 2014).

Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake

Representative model, for educational purposes only.